Schedule I (active research)
Ibogaine Therapy
Ibogaine is being researched for addiction treatment, particularly opioid use disorder. Texas has allocated $50M for ibogaine research at state universities, signaling growing mainstream interest.
7Clinical Trials
3Companies
1Legal States
FDA StatusSchedule I (active research)
Legal PathwayState research programs (Texas $50M allocation)
Also Known Asiboga, ibogaine HCl, noribogaine
Legal Status by State
View full legal tracker →Fully Operational
Legal, Launching
Decriminalized
Active Legislation
Research Only
No Activity
Decriminalized1
CO
Clinical Trials
2 trials currently recruiting
Phase 12
Phase 22
Phase 30
Active, Not Recruiting·N/A·ibogaine
Trifecta Research Study
Axial Therapeutic Research
PTSD - Post Traumatic Stress DisorderCognitive DysfunctionBrain Injury+2 more
Completed·N/A·ibogaine
Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure
Stanford University
Blast or Combat ExposureHead Injury Trauma
Completed·Phase 1·ibogaine
A Study of Oral Ibogaine in Opioid Withdrawal
atai Therapeutics, Inc.
Opiate Withdrawal Syndrome
Completed·Phase 2·ibogaine
Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification
International Center for Ethnobotanical Education, Research, and Service
Drug DependenceDrug Use DisordersOpioid Dependence
Not Yet Recruiting·Phase 1·ibogaine
Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder
Clive Michelsen
Opioid Use DisorderOpioid WithdrawalSubstance Use Disorders
Recruiting·N/A·ibogaine
Mapping Ibogaine Neural Dynamics in Opioid Use Disorder
University of California, Irvine
Opioid Use Disorder (OUD)
Companies & Research
Organizations developing Ibogaine-based therapies